Exact Mass: 228.9985
Exact Mass Matches: 228.9985
Found 402 metabolites which its exact mass value is equals to given mass value 228.9985,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Flonicamid
D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals CONFIDENCE standard compound; EAWAG_UCHEM_ID 2943 EAWAG_UCHEM_ID 2943; CONFIDENCE standard compound
Chloranocryl
CONFIDENCE standard compound; INTERNAL_ID 512; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4881; ORIGINAL_PRECURSOR_SCAN_NO 4879 CONFIDENCE standard compound; INTERNAL_ID 512; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4870; ORIGINAL_PRECURSOR_SCAN_NO 4866 CONFIDENCE standard compound; INTERNAL_ID 512; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4842; ORIGINAL_PRECURSOR_SCAN_NO 4840 CONFIDENCE standard compound; INTERNAL_ID 512; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4863; ORIGINAL_PRECURSOR_SCAN_NO 4858 CONFIDENCE standard compound; INTERNAL_ID 512; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4866; ORIGINAL_PRECURSOR_SCAN_NO 4863 CONFIDENCE standard compound; INTERNAL_ID 512; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4881; ORIGINAL_PRECURSOR_SCAN_NO 4876
Dimethoate
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor CONFIDENCE standard compound; EAWAG_UCHEM_ID 2761 EAWAG_UCHEM_ID 2761; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 8379 CONFIDENCE standard compound; INTERNAL_ID 4003 CONFIDENCE standard compound; INTERNAL_ID 3009 D010575 - Pesticides > D007306 - Insecticides D004791 - Enzyme Inhibitors D016573 - Agrochemicals
Amiloride
A pyrazine compound inhibiting sodium reabsorption through sodium channels in renal epithelial cells. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with diuretics to spare potassium loss. (From Gilman et al., Goodman and Gilmans The Pharmacological Basis of Therapeutics, 9th ed, p705) D049990 - Membrane Transport Modulators > D026941 - Sodium Channel Blockers > D062686 - Epithelial Sodium Channel Blockers D049990 - Membrane Transport Modulators > D026941 - Sodium Channel Blockers > D062646 - Acid Sensing Ion Channel Blockers C - Cardiovascular system > C03 - Diuretics > C03D - Aldosterone antagonists and other potassium-sparing agents C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49186 - Potassium-Sparing Diuretic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics KEIO_ID A225; [MS2] KO008833 KEIO_ID A225
5-Phosphoribosylamine
5-Phosphoribosylamine is a substrate for Amidophosphoribosyltransferase and Trifunctional purine biosynthetic protein adenosine-3. [HMDB] 5-Phosphoribosylamine is a substrate for Amidophosphoribosyltransferase and Trifunctional purine biosynthetic protein adenosine-3. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
clonidine
C - Cardiovascular system > C02 - Antihypertensives > C02A - Antiadrenergic agents, centrally acting > C02AC - Imidazoline receptor agonists S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EA - Sympathomimetics in glaucoma therapy D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2720 INTERNAL_ID 2720; CONFIDENCE standard compound KEIO_ID C191 Clonidine is an alpha 2-adrenergic agonist[1].
Clonidine
Clonidine, an imidazoline-derivative hypotensive agent is a centrally-acting α2-adrenergic agonist. It crosses the blood-brain barrier and acts in the hypothalamus to induce a decrease in blood pressure. It may also be administered as an epidural infusion as an adjunct treatment in the management of severe cancer pain that is not relieved by opiate analgesics alone. Clonidine may be used for differential diagnosis of pheochromocytoma in hypertensive patients. Other uses for clonidine include prophylaxis of vascular migraine headaches, treatment of severe dysmenorrhea, management of vasomotor symptoms associated with menopause, rapid detoxification in the management of opiate withdrawal, treatment of alcohol withdrawal used in conjunction with benzodiazepines, management of nicotine dependence, topical use to reduce intraocular pressure in the treatment of open-angle and secondary glaucoma and hemorrhagic glaucoma associated with hypertension, and in the treatment of attention-deficit hyperactivity disorder (ADHD). Clonidine also exhibits some peripheral activity. C - Cardiovascular system > C02 - Antihypertensives > C02A - Antiadrenergic agents, centrally acting > C02AC - Imidazoline receptor agonists S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EA - Sympathomimetics in glaucoma therapy D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Clonidine is an alpha 2-adrenergic agonist[1].
4-Chloro-6,7-dimethoxy-2-benzoxazolinone
4-Chloro-6,7-dimethoxy-2-benzoxazolinone is found in cereals and cereal products. 4-Chloro-6,7-dimethoxy-2-benzoxazolinone is isolated from light-grown sweet corn shoots (Zea mays Isolated from light-grown sweet corn shoots (Zea mays). 4-Chloro-6,7-dimethoxy-2-benzoxazolinone is found in cereals and cereal products and fats and oils.
5-phospho-beta-D-ribosylaminium(1-)
5-phospho-beta-D-ribosylaminium(1-) is considered to be soluble (in water) and acidic
Phosphorothioic acid, O-(4-cyanophenyl) O-methyl ester
Picric acid
Picric acid, also known as acide picrique or c.i. 10305, belongs to the class of organic compounds known as nitrophenols. Nitrophenols are compounds containing a nitrophenol moiety, which consists of a benzene ring bearing both a hydroxyl group and a nitro group on two different ring carbon atoms. Based on a literature review a significant number of articles have been published on Picric acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). Picric acid is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Picric acid is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. Picric acid. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=88-89-1 (retrieved 2024-07-10) (CAS RN: 88-89-1). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
5-((Thiophen-2-ylmethyl)amino)-1,3,4-thiadiazole-2-thiol
dimethoate
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D010575 - Pesticides > D007306 - Insecticides D004791 - Enzyme Inhibitors D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 3009
AMILORIDE
D049990 - Membrane Transport Modulators > D026941 - Sodium Channel Blockers > D062686 - Epithelial Sodium Channel Blockers D049990 - Membrane Transport Modulators > D026941 - Sodium Channel Blockers > D062646 - Acid Sensing Ion Channel Blockers C - Cardiovascular system > C03 - Diuretics > C03D - Aldosterone antagonists and other potassium-sparing agents C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49186 - Potassium-Sparing Diuretic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics CONFIDENCE standard compound; INTERNAL_ID 1085; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2314; ORIGINAL_PRECURSOR_SCAN_NO 2312 CONFIDENCE standard compound; INTERNAL_ID 1085; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2312; ORIGINAL_PRECURSOR_SCAN_NO 2311 CONFIDENCE standard compound; INTERNAL_ID 1085; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2315; ORIGINAL_PRECURSOR_SCAN_NO 2313 CONFIDENCE standard compound; INTERNAL_ID 1085; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2304; ORIGINAL_PRECURSOR_SCAN_NO 2302 CONFIDENCE standard compound; INTERNAL_ID 1085; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2373; ORIGINAL_PRECURSOR_SCAN_NO 2370 CONFIDENCE standard compound; INTERNAL_ID 1085; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2315; ORIGINAL_PRECURSOR_SCAN_NO 2314 CONFIDENCE standard compound; INTERNAL_ID 1085; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4866; ORIGINAL_PRECURSOR_SCAN_NO 4864 CONFIDENCE standard compound; INTERNAL_ID 1085; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4878; ORIGINAL_PRECURSOR_SCAN_NO 4875 CONFIDENCE standard compound; INTERNAL_ID 1085; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4900; ORIGINAL_PRECURSOR_SCAN_NO 4899 CONFIDENCE standard compound; INTERNAL_ID 1085; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4909; ORIGINAL_PRECURSOR_SCAN_NO 4907 INTERNAL_ID 1085; CONFIDENCE standard compound; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4909; ORIGINAL_PRECURSOR_SCAN_NO 4907 CONFIDENCE standard compound; INTERNAL_ID 1085; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4914; ORIGINAL_PRECURSOR_SCAN_NO 4912 CONFIDENCE standard compound; INTERNAL_ID 1085; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4905; ORIGINAL_PRECURSOR_SCAN_NO 4903 CONFIDENCE standard compound; INTERNAL_ID 9; HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu) INTERNAL_ID 9; CONFIDENCE standard compound; HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu) CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu); Flow Injection Flow Injection; CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu) CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu)
Thiourea,N-[1-(3-chloro-4-pyridinyl)ethyl]-N-methyl-
2-(Chloromethyl)thiazole-2yl Guanidine Hydrochloride
2-(2-FORMYLAMINO-1,3-THIAZOL-4-YL)-2-(METHOXYIMINO)ACETIC ACID
Pyrimidine,5-(bromomethyl)-4-(dimethylamino)-2-methyl-(8CI)
4-amino-3-bromo-5-methylbenzoic acid(SALTDATA: FREE)
3-[3-(Trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-amine
2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHANAMINE HYDROCHLORIDE
Lamprecide
A lampricide is any chemical designed to target the larvae of lampreys in river systems before they develop into parasitic adults. One lampricide is used in the headwaters of Lake Champlain and the Great Lakes to control the sea lamprey (Petromyzon marinus), an invasive species to these lakes.[1] TFM (3-trifluoromethyl-4-nitrophenol) is the main chemical used for this purpose. As it is hydrophobic, it passes through biological membranes.[2] TFM is a metabolic uncoupler—that is, TFM separates the electron transport chain from ATP synthesis, resulting in the failure of the aerobic respiration process. It accomplishes this by disrupting the electrochemical gradient that powers ATP synthase—as an acid, it donates H+ ions to the mitochondrial matrix. The electron transport chain is not affected and continues using oxygen, without producing ATP. While the general opinion is that TFM typically does not harm other fish (due to the relationship between true fish and lampreys), lampricide can be problematic for many amphibians, such as mudpuppies (genus Necturus) which often share the same habitats. Also, some more "primitive" species of fish, such as the sturgeon in the Great Lakes are sensitive to chemicals such as TFM. Lamprecide is a metabolic compound that has been identified in various biological contexts, although it is not as widely recognized as some other metabolites. The term "lamprecide" is less commonly used in scientific literature, and therefore, detailed information about this specific metabolite may be limited. However, the name suggests that it could be associated with the metabolism of lampreys, which are a type of jawless fish, or it might be a compound with a similar structure to other known metabolites or alkaloids. As a metabolite, lamprecide is likely to be a small molecule that is produced as part of the normal metabolic processes within an organism. It may have various biological roles, such as serving as a signaling molecule, a precursor to other compounds, or having a specific physiological function within the organism that produces it. In the context of its chemical structure, lamprecide might be characterized by a unique arrangement of atoms that gives it specific properties. These properties could include a particular reactivity, solubility, or interaction with biological macromolecules like proteins or nucleic acids. Without specific details on the exact structure and function of lamprecide, a more precise description is not possible. If lamprecide is a novel or less-studied metabolite, further research would be needed to determine its: - Chemical structure: The exact arrangement of atoms and functional groups that define the molecule. - Biosynthesis: The metabolic pathways and enzymes involved in the production of lamprecide. - Bioactivity: Any potential pharmacological or toxicological effects it may have on biological systems. - Role in metabolism: Its function within the organism, such as enzyme inhibition, hormone activity, or as a structural component. For a more accurate and detailed description, one would need to refer to the scientific literature or research studies that specifically investigate this compound. Phenol, 4-nitro-3-(trifluoromethyl)-, sodium salt (1:1). CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=654-66-0 (retrieved 2024-07-10) (CAS RN: 654-66-0). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
7-CHLORO-5-(PROPYLTHIO)-1H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE
5-CHLORO-2-METHYL-3-NITRO-BENZOIC ACID METHYLESTER
2-Chloro-6H-thieno[2,3-b]pyrrole-5-carboxylic acid ethyl ester
(z)-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetic acid
(5R)-5-(Chloromethyl)-3-(3-fluorophenyl)-2-oxazolidinone
5-chloro-2-(chloromethyl)-3-(trifluoromethyl)pyridine
Ethyl 5-Nitro-2,6-Dioxo-3H-Pyrimidine-4-Carboxylate
2,2,2-Trifluoro-1-(3-fluorophenyl)ethylaminehydrochloride
4-(4-Chlorophenyl)-1,2,3,6-tetrahydropyridine hydrochloride
4-CHLORO-2-(METHYLTHIO)-6-(PYRROLIDIN-1-YL)PYRIMIDINE
2-(3-METHYL-THIOPHEN-2-YL)-THIAZOLIDINE-4-CARBOXYLIC ACID
3-Chloro-5-(ethoxycarbonyl)-pyridine-2-carboxylic acid
O,O-Dimethyl S-[2-(methylamino)-2-oxoethyl] phosphorodithioate
2,4-dichloro-6-(2H-1,2-oxazol-5-ylidene)cyclohexa-2,4-dien-1-one
1H-Pyrrolo[2,3-b]pyridin-3-amine, 5-bromo-4-fluoro-
1,3-Bis(chloromethyl)-1,1,3,3-tetra methyldisilazane
4-Fluoro-N-methyl-3-(trifluoromethyl)aniline hydrochloride
4-Fluoro-N-methyl-2-(trifluoromethyl)aniline hydrochloride
6-Chloropyridine-2,3-Dicarboxylic Acid Dimethyl Ester
2-Methyl-4-(trifluoromethyl)-1,3-thiazole-5-carbonyl chloride
4-chloro-6-methyl-2-phenylpyrimidine-5-carbonitrile
2-(2-Formamidothiazole-4-yl)-2-methoxyimino acetic acid
5-AMINO-3-METHYL-THIOPHENE-2,4-DICARBOXYLIC ACID DIMETHYL ESTER
3-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)aniline
POLY(2-ACRYLAMIDO-2-METHYLPROPANE SULFONIC ACID), SODIUM SALT
8-AMINO-7-CHLORO-2,3-DIHYDROBENZO[B][1,4]DIOXINE-5-CARBOXYLIC ACID
(1S)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride ( 1:1)
6-(PYRIDIN-3-YL)IMIDAZO[2,1-B]THIAZOLE-5-CARBALDEHYDE
6-(PYRIDIN-4-YL)IMIDAZO[2,1-B]THIAZOLE-5-CARBALDEHYDE
3-CHLORO-2-(CHLOROMETHYL)-5-(TRIFLUOROMETHYL)PYRIDINE
2-Amino-3,4-thiophenedicarboxylic acid 3-ethyl 4-methyl ester
2-Pyrrolidinecarbonyl chloride, 1-(trifluoroacetyl)-
Phosphorothioic acid, O-(4-cyanophenyl) O-methyl ester
Methyl 3-(Methylsulfonylamino)benzoate
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-Amino-3-[(2,5-dihydroxyphenyl)sulfanyl]propanoate
2-Amino-3-(2,5-dihydroxyphenyl)sulfanylpropanoic acid
2-{[Iminio(phosphonatoamino)methyl]amino}ethanesulfinate
Methyl 2-[(2-methoxyacetyl)amino]thiophene-3-carboxylate
5-Phospho-beta-D-ribosylamine
The beta-anomer of 5-phospho-D-ribosylamine. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Picric acid
C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D004791 - Enzyme Inhibitors > D014475 - Uncoupling Agents
